Apr 11, 2018 - Chao Xing, Xian-Jin Xie, Brian York, Kathryn A. O'Donnell. The following information is missing from the Funding section: This work was ...
CORRECTION
Correction: SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer Shruthy Suresh, Deniz Durakoglugil, Xiaorong Zhou, Bokai Zhu, Sarah A. Comerford, Chao Xing, Xian-Jin Xie, Brian York, Kathryn A. O’Donnell
The following information is missing from the Funding section: This work was supported by The Cancer Prevention Research Institute of Texas (http://www.cprit.state.tx.us/) (RP160157 to SS).
Reference 1.
Suresh S, Durakoglugil D, Zhou X, Zhu B, Comerford SA, Xing C, et al. (2017) SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer. PLoS Genet 13(3): e1006650. https://doi.org/10.1371/journal.pgen.1006650 PMID: 28273073
a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
OPEN ACCESS Citation: Suresh S, Durakoglugil D, Zhou X, Zhu B, Comerford SA, Xing C, et al. (2018) Correction: SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer. PLoS Genet 14(4): e1007344. https://doi.org/ 10.1371/journal.pgen.1007344 Published: April 11, 2018 Copyright: © 2018 Suresh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007344 April 11, 2018
1/1
